WHWK (Whitehawk Therapeutics) Change In Inventory : $1.12 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Whitehawk Therapeutics Change In Inventory?

Whitehawk Therapeutics's change in inventory for the quarter that ended in Dec. 2024 was $0.16 Mil. It means Whitehawk Therapeutics's inventory declined by $0.16 Mil from Sep. 2024 to Dec. 2024 .

Whitehawk Therapeutics's change in inventory for the fiscal year that ended in Dec. 2024 was $1.12 Mil. It means Whitehawk Therapeutics's inventory declined by $1.12 Mil from Dec. 2023 to Dec. 2024 .

Whitehawk Therapeutics's Total Inventories for the quarter that ended in Dec. 2024 was $5.31 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Whitehawk Therapeutics's Days Inventory for the quarter that ended in Dec. 2024 was 622.52.

Inventory Turnover measures how fast the company turns over its inventory within a year. Whitehawk Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.15.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Whitehawk Therapeutics's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.74.

Whitehawk Therapeutics Change In Inventory Historical Data

The historical data trend for Whitehawk Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whitehawk Therapeutics Change In Inventory Chart

Whitehawk Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

-1.86

-3.27

1.12

Whitehawk Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial													-2.23	0.49	-0.16	0.63	0.16

Whitehawk Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.12 Mil.

Whitehawk Therapeutics (NAS:WHWK) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Whitehawk Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5.3895	/	0.79	*	365 / 4
	=	622.52

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Whitehawk Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.79	/	5.3895
	=	0.15

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Whitehawk Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5.3895	/	7.239
	=	0.74

Whitehawk Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Whitehawk Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Whitehawk Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Whitehawk Therapeutics Inc (NAS:WHWK) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

3350:Germany

Address

2 Headquarters Plaza East Building, 11th Floor, Morristown, New Jersey, NJ, USA, 07960

Website

https://www.whitehawktx.com

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Executives

David James Lennon	director, officer: Chief Executive Officer	C/O AADI BIOSCIENCE, INC., 17383 SUNSET BLVD, SUITE A250, PACIFIC PALISADES CA 90272
Scott M. Giacobello	officer: Chief Financial Officer	SOVEREIGN HOUSE, VISION PARK, HISTON, CAMBRIDGE X0 CB24 9BZ
Neil Desai	director, officer: See Remarks	C/O AADI BIOSCIENCE, INC., 17383 SUNSET BLVD., SUITE A250, PACIFIC PALISADES CA 90272
Mohammad Hirmand	director	C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105
Lorettta M Itri	officer: Chief Medical Officer
Brendan Delaney	officer: Chief Operating Officer	300 THE AMERICAN WAY, MORRIS PLAINS NJ 07950
Emma Reeve	director	C/O PAREXEL INTERNATIONAL CORPORATION, 195 WEST STREET, WALTHAM MA 02451
Karin M. Hehenberger	director	C/O CORONADO BIOSCIENCES, INC., 15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON CO 01803
Richard E Maroun	director	C/O AADI BIOSCIENCE, INC., 17383 SUNSET BLVD., SUITE A250, PACIFIC PALISADES CA 90272
Caley Castelein	director	THOM. WEISEL HEALTHCARE VENTURES, ONE MONTGOMERY STREET, SAN FRANCISCO CA 94104
Lance E Thibault	officer: Chief Financial Officer
Behzad Aghazadeh	director, other: See Remarks	C/O AVORO CAPITAL ADVISORS LLC, 110 GREENE STREET, SUITE 800, NEW YORK NY 10012
Venbio Select Advisor Llc	director, other: See Remarks	110 GREENE STREET, SUITE 800, NEW YORK NY 10012
Anupam Dalal	director	88 KEARNY STREET, SUITE 1800, SAN FRANCISCO CA 94108
Avoro Ventures Llc	director, other: See Remarks	110 GREEN STREET, SUITE 800, NEW YORK NY 10012